These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 2783864

  • 1. In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.
    Johnson CS, Keckler DJ, Topper MI, Braunschweiger PG, Furmanski P.
    Blood; 1989 Feb 15; 73(3):678-83. PubMed ID: 2783864
    [Abstract] [Full Text] [Related]

  • 2. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H, Guilbert LJ, Janowska-Wieczorek A.
    Exp Hematol; 1990 Mar 15; 18(3):174-9. PubMed ID: 2303109
    [Abstract] [Full Text] [Related]

  • 3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS, Hughes NK, Hulette BC, Noblitt L.
    J Leukoc Biol; 1991 Dec 15; 50(6):580-6. PubMed ID: 1940611
    [Abstract] [Full Text] [Related]

  • 4. In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis.
    Johnson CS, Braunschweiger PG, Furmanski P.
    In Vivo; 1990 Dec 15; 4(2):93-6. PubMed ID: 2129805
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.
    Exp Hematol; 1997 Sep 15; 25(10):1025-33. PubMed ID: 9293899
    [Abstract] [Full Text] [Related]

  • 6. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr 15; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 7. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood.
    Mizuguchi T, Kosaka M, Saito S.
    Blood; 1993 Jun 01; 81(11):2891-7. PubMed ID: 8499628
    [Abstract] [Full Text] [Related]

  • 8. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G.
    Exp Hematol; 1999 Mar 01; 27(3):416-24. PubMed ID: 10089903
    [Abstract] [Full Text] [Related]

  • 9. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS, Shedlofsky SI, Swim AT, Robinson JM, Hulette BC, Messino MJ, Doukas MA.
    J Biol Response Mod; 1989 Aug 01; 8(4):422-39. PubMed ID: 2666587
    [Abstract] [Full Text] [Related]

  • 10. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
    Johnson CS, Cook CA, Furmanski P.
    Exp Hematol; 1990 Feb 01; 18(2):109-13. PubMed ID: 2303102
    [Abstract] [Full Text] [Related]

  • 11. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
    Mide SM, Huygens P, Bozzini CE, Fernandez Pol JA.
    In Vivo; 2001 Feb 01; 15(2):125-32. PubMed ID: 11317516
    [Abstract] [Full Text] [Related]

  • 12. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
    Gallicchio VS, Hughes NK.
    Proc Soc Exp Biol Med; 1992 Apr 01; 199(4):459-65. PubMed ID: 1549625
    [Abstract] [Full Text] [Related]

  • 13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 14. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S.
    Blood; 1995 Sep 01; 86(5):1661-70. PubMed ID: 7544638
    [Abstract] [Full Text] [Related]

  • 15. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
    Mitjavila MT, Natazawa M, Brignaschi P, Debili N, Breton-Gorius J, Vainchenker W.
    J Cell Physiol; 1989 Mar 01; 138(3):617-23. PubMed ID: 2647773
    [Abstract] [Full Text] [Related]

  • 16. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
    Dai CH, Krantz SB, Dessypris EN, Means RT, Horn ST, Gilbert HS.
    Blood; 1992 Aug 15; 80(4):891-9. PubMed ID: 1498332
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE, Erickson-Miller CL, Murphy MJ.
    Stem Cells; 1997 Aug 15; 15(4):286-90. PubMed ID: 9253112
    [Abstract] [Full Text] [Related]

  • 18. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS, Hughes NK, Tse KF.
    Growth Regul; 1994 Jun 15; 4(2):41-7. PubMed ID: 7950902
    [Abstract] [Full Text] [Related]

  • 19. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W, Kurtzberg J.
    Ann Hematol; 1993 Dec 15; 67(6):267-76. PubMed ID: 7506580
    [Abstract] [Full Text] [Related]

  • 20. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
    Briggs M, Adams JA, Brereton ML, Burgess R, Hyde K, Lenehan H, Yin JA.
    Br J Haematol; 2001 Dec 15; 115(3):563-8. PubMed ID: 11736936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.